This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Tianjin Xiji Biotechnology Co., Ltd., The Queen's University of Belfast. Active years: 2011-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011-2016
Title: Pingfan Rao: Innovator in HIV Treatment
Introduction
Pingfan Rao is a notable inventor based in Fuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of HIV infection and related symptoms. With a total of 3 patents, his work focuses on innovative solutions to combat this global health issue.
Latest Patents
Rao's latest patents include groundbreaking pharmaceutical compositions and methods for using fusion proteins. One of his notable inventions describes a fusion protein that combines superoxide dismutase with a transit peptide. This invention outlines methods for treating patients with HIV infection and AIDS-related symptoms. Additionally, he has developed pharmaceutical compositions that utilize this fusion protein in combination with other antiretroviral agents, enhancing treatment efficacy for those affected by AIDS or HIV.
Career Highlights
Throughout his career, Pingfan Rao has worked with various organizations, including Tianjin Xiji Biotechnology Co., Ltd. and The Queen's University of Belfast. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative treatments.
Collaborations
Rao has collaborated with several professionals in his field, including Shutao Liu and Chris Shaw. These partnerships have facilitated the exchange of ideas and expertise, further enriching his research endeavors.
Conclusion
Pingfan Rao's contributions to the field of HIV treatment through his innovative patents highlight his dedication to improving patient outcomes. His work continues to inspire advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile